Search All Resources
Addiction Treatment and the HCV Provider | February 12, 2019
Dr. Jessica Gregg, Associate Professor of Medicine at Oregon Health and Science University, discusses the relationship between the opioid epidemic and HCV infections as well as the different treatments available for those suffering from opioid use disorder.
Date added: 02/12/19
Medications for OUD: Who Should Get What When? | February 7, 2019
Type: Past Presentation
Audience: Clinical
Program: Substance Use Disorder
Keywords: #buprenorphine #mat #methadone #naltrexone
Dr. Jessica Gregg, Associate Professor of Medicine at Oregon Health and Science University, compares buprenorphine, methadone, and extended release naltrexone in terms of efficacy, induction, retention, operational restraints, and other clinical variables when used for treating opioid use disorder.
Date added: 02/7/19
HCV Elimination | January 23, 2019
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #cherokee hcv elimination #hcv elimination #micro-elimination
Dr. Jorge Mera, Director of Infectious Diseases for the Cherokee Nation Health Service, provides a general overview of HCV elimination and micro-elimination, as well as an overview of the Cherokee Nation HCV Elimination Program.
Date added: 01/23/19
Neurobiology and Diagnosis of SUDs | January 17, 2019
Type: Past Presentation
Audience: Clinical
Program: Substance Use Disorder
Keywords: #neurobiology #sud diagnostic criteria
Dr. Jessica Gregg, Associate Professor of Medicine at Oregon Health and Science University, reviews the diagnostic criteria for substance use disorders and examines the different ways in which substance use disorders can develop.
Date added: 01/17/19
The Impact of SVR on Cirrhosis and Non-Liver Complications | December 11, 2018
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #cirrhosis #direct acting antiviral #interferon treatment #liver disease #sustained virologic response
Annette Hewitt and Lisa Townshend-Bulson, Family Nurse Practitioners from the Alaska Native Tribal Health Consortium, Liver Disease & Hepatitis Program, present on the impact of sustained virologic response (SVR) on cirrhosis and non-liver complications in both direct acting antiviral (DAA) ...
Date added: 12/11/18
Opioid Substitution Therapy and the HCV-Provider | November 28, 2018
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #hcv and opioids #opioid substitution therapy #opioids
Dr. Aaron Skiles, a Family Nurse Practitioner with the UNM Sandoval Regional Medical Center, shares knowledge on the opioid epidemic, the merits of opioid substitution therapy, and the role of the HCV care provider in treating opioid use disorder.
Date added: 11/28/18
HCV in Pregnant Women: How the Opioid Crisis is Changing the Landscape | September 26, 2018
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #hcv and children #hcv and opioids #hcv and pregnancy #maternal child health #opioids
Dr. Francheska Sevy Gurule, a Maternal Child Health Fellow at the University of New Mexico, Department of Family and Community Medicine, presents on the impact the opioid crisis has had on the prevalence of HCV in pregnant women.
Date added: 09/26/18
Interdisciplinary Care at Shoshone-Bannock | September 13, 2018
Type: Past Presentation
Audience: Clinical
Program: Diabetes
Keywords: #interdisciplinary care #shoshone-bannock
A brief overview of healthcare services offered at the Shoshone-Bannock Fort Hall IHS facility and the Shoshone-Bannock Department of Tribal Health and Human Services, as well as the design and impact of a quality improvement study conducted by the Tribe.
Date added: 09/13/18
Long Term Follow-Up After HCV Treatment | September 11, 2018
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #hcv treatment #reinfection prevention #treatment follow-up
Dr. Paulina Deming, an Associate Professor of Pharmacy at the University of New Mexico Sciences Center, discusses the needed follow-up for patients with and without cirrhosis who have completed HCV treatment, including counseling on lifestyle changes to prevent reinfection.
Date added: 09/11/18
Addressing Transient Elastography (FibroScan): Integrating with HCV Care | Addressing Starting an HCV Clinic at Crow/Northern Cheyenne | August 25, 2018
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #elastography #fibroscan #hcv elimination #lummi
Dr. Justin Iwasaki, the Executive Medical Director at Lummi Tribal Health Center (LTHC), discusses the creation and design considerations of the HCV Elimination Program at the LTHC, and then he provides an overview of FibroScan technology. Also, a team from ...
Date added: 08/25/18